Cha YJ - Search Results

1

Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h + HER2- breast cancer: a retrospective analysis.

Kook Y, Lee YJ, Chu C, Jang JS, Baek SH, Bae SJ, Cha YJ, Gong G, Jeong J, Lee SB, Ahn SG. Kook Y, et al. Among authors: cha yj. Breast Cancer Res. 2024 Nov 6;26(1):154. doi: 10.1186/s13058-024-01911-9. Breast Cancer Res. 2024. PMID: 39506855 Free PMC article.

2

Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.

Cha YJ, Jung WH, Koo JS. Cha YJ, et al. Dis Markers. 2017;2017:7062517. doi: 10.1155/2017/7062517. Epub 2017 Feb 2. Dis Markers. 2017. PMID: 28260828 Free PMC article.

3

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.

Ahn SG, Bae SJ, Yoon C, Cha YJ, Lee HW, Lee SA, Jeong J. Ahn SG, et al. Among authors: cha yj. PLoS One. 2017 Nov 8;12(11):e0187679. doi: 10.1371/journal.pone.0187679. eCollection 2017. PLoS One. 2017. PMID: 29117208 Free PMC article.

4

Subtypes of breast cancer show different spatial distributions of brain metastases.

Kyeong S, Cha YJ, Ahn SG, Suh SH, Son EJ, Ahn SJ. Kyeong S, et al. Among authors: cha yj. PLoS One. 2017 Nov 20;12(11):e0188542. doi: 10.1371/journal.pone.0188542. eCollection 2017. PLoS One. 2017. PMID: 29155879 Free PMC article.

5

Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.

Sun WY, Choi J, Cha YJ, Koo JS. Sun WY, et al. Among authors: cha yj. Int J Mol Sci. 2017 Dec 20;18(12):2775. doi: 10.3390/ijms18122775. Int J Mol Sci. 2017. PMID: 29261141 Free PMC article.

6

Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.

Cha YJ, Kim ES, Koo JS. Cha YJ, et al. Breast Cancer Res Treat. 2018 Jul;170(1):15-25. doi: 10.1007/s10549-018-4722-1. Epub 2018 Feb 21. Breast Cancer Res Treat. 2018. PMID: 29468486

7

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer.

Ahn SG, Cha YJ, Bae SJ, Yoon C, Lee HW, Jeong J. Ahn SG, et al. Among authors: cha yj. BMC Cancer. 2018 Mar 24;18(1):320. doi: 10.1186/s12885-018-4228-6. BMC Cancer. 2018. PMID: 29573739 Free PMC article.

8

Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.

Cha YJ, Ahn SG, Bae SJ, Yoon CI, Seo J, Jung WH, Son EJ, Jeong J. Cha YJ, et al. Breast Cancer Res Treat. 2018 Sep;171(2):295-302. doi: 10.1007/s10549-018-4842-7. Epub 2018 Jun 5. Breast Cancer Res Treat. 2018. PMID: 29869774

9

Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV.

Ahn SG, Yoon CI, Lee JH, Lee HS, Park SE, Cha YJ, Cha C, Bae SJ, Lee KA, Jeong J. Ahn SG, et al. Among authors: cha yj, cha c. Endocr Relat Cancer. 2019 Feb;26(2):177-185. doi: 10.1530/ERC-18-0281. Endocr Relat Cancer. 2019. PMID: 30407916 Free PMC article.

10

Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.

Park S, Cha YJ, Suh SH, Lee IJ, Lee KS, Hong CK, Kim JW. Park S, et al. Among authors: cha yj. J Cancer Res Clin Oncol. 2019 May;145(5):1351-1360. doi: 10.1007/s00432-019-02891-6. Epub 2019 Apr 5. J Cancer Res Clin Oncol. 2019. PMID: 30953136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters